Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of ...
Neuroscience trials require high-precision, sensitive endpoint measurements, yet sponsors often face challenges with ...
The market opportunities lie in comprehensive training on cross-regional veterinary medicine development, emphasizing regulatory and commercial strategies for the EU and USA. The course fosters ...
The main market opportunities include leveraging the growing segment of combination products, emphasizing safety and efficacy in design through effective risk management, and navigating regulatory ...
This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Life sciences is among the most ...
The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions. The FDA Fast ...
Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in drug ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results